BDBM350539 1-(4-bromophenyl)-3-[4-ethyl- 2,5-dioxo-4-(2- phenylethyl)imidazolidin-1- yl]urea::US10208071, Compound 1::US10434112, Compound 1::US10799518, Compound 1

SMILES CCC1(CCc2ccccc2)NC(=O)N(NC(=O)Nc2ccc(Br)cc2)C1=O

InChI Key InChIKey=WZUBWDFMPJHXBA-UHFFFAOYSA-N

Data  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 350539   

TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350539(1-(4-bromophenyl)-3-[4-ethyl- 2,5-dioxo-4-(2- phen...)
Affinity DataEC50:  3.00E+3nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350539(1-(4-bromophenyl)-3-[4-ethyl- 2,5-dioxo-4-(2- phen...)
Affinity DataEC50:  3.00E+3nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350539(1-(4-bromophenyl)-3-[4-ethyl- 2,5-dioxo-4-(2- phen...)
Affinity DataEC50:  3.00E+3nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent